The pharmacology of bisphosphonates and new insights into their mechanisms of action

被引:202
作者
Russell, RGG
Rogers, MJ
Frith, JC
Luckman, SP
Coxon, FP
Benford, HL
Croucher, PI
Shipman, C
Fleisch, HA
机构
[1] Univ Sheffield, Sch Med, Dept Human Metab & Clin Biochem, Sheffield S10 2RX, S Yorkshire, England
[2] Univ Aberdeen, Dept Med & Therapeut, Bone Res Grp, Aberdeen, Scotland
关键词
D O I
10.1002/jbmr.5650140212
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bisphosphonates are chemically stable analogs of inorganic pyrophosphate, which are resistant to breakdown by enzymatic hydrolysis, The biological effects of bisphosphonates on calcium metabolism were originally ascribed to their physico-chemical effects on hydroxyapatite crystals. Although such effects may contribute to their overall action, their effects on cells are probably of greater importance, particularly for the more potent compounds. Remarkable progress has been made in increasing the potency of bisphosphonates as inhibitors of bone resorption, and the most potent compounds in current use are characterized by the presence of a nitrogen atom at critical positions in the side chain which, together with the bisphosphonate moiety itself, seems to be essential for maximal activity, As a class the bisphosphonates offer a very effective means of treating Paget's disease.
引用
收藏
页码:53 / 65
页数:13
相关论文
共 141 条
[1]   Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis [J].
Adachi, JD ;
Bensen, WG ;
Brown, J ;
Hanley, D ;
Hodsman, A ;
Josse, R ;
Kendler, DL ;
Lentle, B ;
Olszynski, W ;
SteMarie, LG ;
Tenenhouse, A ;
Chines, AA .
NEW ENGLAND JOURNAL OF MEDICINE, 1997, 337 (06) :382-387
[2]   THE ACUTE-PHASE RESPONSE AFTER BISPHOSPHONATE ADMINISTRATION [J].
ADAMI, S ;
BHALLA, AK ;
DORIZZI, R ;
MONTESANTI, F ;
ROSINI, S ;
SALVAGNO, G ;
LOCASCIO, V .
CALCIFIED TISSUE INTERNATIONAL, 1987, 41 (06) :326-331
[3]   Adverse effects of bisphosphonates - A comparative review [J].
Adami, S ;
Zamberlan, N .
DRUG SAFETY, 1996, 14 (03) :158-170
[4]  
Amin D, 1996, ARZNEIMITTEL-FORSCH, V46, P759
[5]  
AMIN D, 1992, J LIPID RES, V33, P1657
[6]  
[Anonymous], BISPHOSPHONATES BONE
[7]   Identification of adenine nucleotide-containing metabolites of bisphosphonate drugs using ion-pair liquid chromatography-electrospray mass spectrometry [J].
Auriola, S ;
Frith, J ;
Rogers, MJ ;
Koivuniemi, A ;
Mönkkönen, J .
JOURNAL OF CHROMATOGRAPHY B, 1997, 704 (1-2) :187-195
[8]   ALENDRONATE DISTRIBUTED ON BONE SURFACES INHIBITS OSTEOCLASTIC BONE-RESORPTION IN-VITRO AND IN EXPERIMENTAL HYPERCALCEMIA MODELS [J].
AZUMA, Y ;
SATO, H ;
OUE, Y ;
OKABE, K ;
OHTA, T ;
TSUCHIMOTO, M ;
KIYOKI, M .
BONE, 1995, 16 (02) :235-245
[9]   Efficacy of pamidronate in reducing skeletal events in patients with advanced multiple myeloma [J].
Berenson, JR ;
Lichtenstein, A ;
Porter, L ;
Dimopoulos, MA ;
Bordoni, R ;
George, S ;
Lipton, A ;
Keller, A ;
Ballester, O ;
Kovacs, MJ ;
Blacklock, HA ;
Bell, R ;
Simeone, J ;
Reitsma, DJ ;
Heffernan, M ;
Seaman, J ;
Knight, RD .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 334 (08) :488-493
[10]  
BIJVOET OLM, 1995, BISPHOSPHONATES BONE